Portfolio
About Us
How it works
Latest Articles

PHASE III OPEN LABEL CLINICAL STUDY

Neurotech embarks on ground-breaking ASD trials

Connect with us

customer notice
privacy policy
financial services guide
disclosure policy
contact

The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).

Subscribe for updates on our small cap, ASX listed biotech portfolio.

Thanks for subscribing!

X